ABBV AbbVie Inc. Common Stock

NYSE · Biotechnology · View on SEC EDGAR ↗

$213.51

Price · May 20, 2026

Fundamentals as of May 8, 2026

ABBV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price

$213.51

Market Cap

—

P/E (TTM)

96.8

EPS (TTM)

$2.36

Revenue (TTM)

$61.16B

Div Yield

—

ROE

15367.3%

Debt/Equity

-0.8

52W Range

$180 – $245

ABBV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $61.16B

2016-12-31 → 2025-12-31

EPS $2.36

2016-12-31 → 2025-12-31

Free Cash Flow $17.82B

2016-12-31 → 2025-12-31

Margins 6.9%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric

5Y trend

ABBV

Peer Median

P/E (TTM)

96.8

25.2

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric

5Y trend

ABBV

Peer Median

Operating Margin

24.6%

—

Net Profit Margin

6.9%

16.0%

ROA

3.1%

5.7%

ROE

15367.3%

21.8%

ROIC

-1254.6%

—

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric

5Y trend

ABBV

Peer Median

Debt / Equity

-0.8

55.8

Current Ratio

0.7

2.5

Quick Ratio

0.4

—

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric

5Y trend

ABBV

Peer Median

Revenue YoY

8.6%

—

Revenue CAGR 3Y

1.8%

—

Revenue CAGR 5Y

5.9%

—

EPS YoY

-1.3%

—

Net Income YoY

-1.2%

—

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric

5Y trend

ABBV

Peer Median

EPS (Diluted)

$2.36

—

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric

5Y trend

ABBV

Peer Median

Payout Ratio

275.8%

—

Dividends Yield, payout ratio, dividend history, 5Y CAGR

Dividend Yield

—

Payout Ratio

275.8%

5Y Div CAGR

—

Ex-date	Amount
April 15, 2026	$1.7300
Jan. 16, 2026	$1.7300
Oct. 15, 2025	$1.6400
July 15, 2025	$1.6400
April 15, 2025	$1.6400
Jan. 15, 2025	$1.6400
Oct. 15, 2024	$1.5500
July 15, 2024	$1.5500
April 12, 2024	$1.5500
Jan. 12, 2024	$1.5500
Oct. 12, 2023	$1.4800
July 13, 2023	$1.4800
April 13, 2023	$1.4800
Jan. 12, 2023	$1.4800
Oct. 13, 2022	$1.4100
July 14, 2022	$1.4100
April 13, 2022	$1.4100
Jan. 13, 2022	$1.4100
Oct. 14, 2021	$1.3000
July 14, 2021	$1.3000

ABBV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 40 analysts

Strong Buy 8 20.0%
Buy 22 55.0%
Hold 10 25.0%
Sell 0 0.0%
Strong Sell 0 0.0%

12-Month Price Target

29 analysts · 2026-05-19

Median $258.00

Now $213.51

Low $184.00

High $328.00

Median target $258.00 +20.8%

Mean target $252.90 +18.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise

0.02%

Period	EPS Actual	EPS Est	Surprise
March 31, 2026	$2.65	$2.65	0.00%
Dec. 31, 2025	$2.71	$2.71	0.00%
Sept. 30, 2025	$1.86	$1.81	0.05%
June 30, 2025	$2.97	$2.94	0.03%
March 31, 2025	$2.46	$2.43	0.03%

Peer Comparison Key metrics vs sector peers

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
ABBV	—	96.8	8.6%	6.9%	15367.3%	—
AMGN	$176.35B	23.0	10.0%	21.0%	95.9%	—
GILD	$152.32B	18.1	2.4%	28.9%	40.5%	—
VRTX	$115.15B	29.6	8.9%	32.9%	22.1%	—
REGN	$106.21B	18.6	0.99%	31.4%	14.7%	—
ALNY	$52.64B	170.7	65.2%	8.5%	60.4%	—
RVMD	—	—	—	—	—	—

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 15

Annual Income Statement data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$61.16B	$56.33B	$54.32B	$58.05B	$56.20B	$45.80B	$33.27B	$32.75B	$28.22B	$25.64B	$22.86B	$19.96B
Cost of Revenue	$18.20B	$16.90B	$20.41B	$17.41B	$17.45B	$15.39B	$7.44B	$7.72B	$7.04B	$5.83B	$4.50B	$4.43B
SG&A Expense	$14.01B	$14.75B	$12.87B	$15.26B	$12.35B	$11.30B	$6.94B	$7.40B	$6.29B	$5.88B	$6.39B	$7.72B
Operating Expenses	$46.09B	$47.20B	$41.56B	$39.94B	$38.27B	$34.44B	$20.28B	$26.37B	$18.67B	$16.30B	$15.32B	$16.55B
Operating Income	$15.07B	$9.14B	$12.76B	$18.12B	$17.92B	$11.36B	$12.98B	$6.38B	$9.54B	$9.34B	$7.54B	$3.41B
Interest Expense	$2.89B	$2.81B	$2.22B	$2.23B	$2.42B	$2.45B	$1.78B	$1.35B	$1.15B	$1.05B	$719M	$429M
Other Non-op	$-5.79B	$-3.24B	$-4.68B	$-2.45B	$-2.50B	$-5.61B	$-3.01B	$-18M	$-466M	$-188M	$-13M	$27M
Pretax Income	$6.60B	$3.72B	$6.25B	$13.48B	$12.99B	$3.40B	$8.43B	$5.20B	$7.73B	$7.88B	$6.64B	$2.37B
Income Tax	$2.36B	$-570M	$1.38B	$1.63B	$1.44B	$-1.22B	$544M	$-490M	$2.42B	$1.93B	$1.50B	$595M
Net Income	$4.23B	$4.28B	$4.86B	$11.84B	$11.54B	$4.62B	$7.88B	$5.69B	$5.31B	$5.95B	$5.14B	$1.77B
EPS (Basic)	$2.37	$2.40	$2.73	$6.65	$6.48	$2.73	$5.30	$3.67	$3.31	$3.65	$3.15	$1.11
EPS (Diluted)	$2.36	$2.39	$2.72	$6.63	$6.45	$2.72	$5.28	$3.66	$3.30	$3.63	$3.13	$1.10
Shares (Basic)	1,769,000,000	1,769,000,000	1,768,000,000	1,771,000,000	1,770,000,000	1,667,000,000	1,481,000,000	1,541,000,000	1,596,000,000	1,622,000,000	1,625,000,000	1,595,000,000
Shares (Diluted)	1,773,000,000	1,773,000,000	1,773,000,000	1,778,000,000	1,777,000,000	1,673,000,000	1,484,000,000	1,546,000,000	1,603,000,000	1,631,000,000	1,637,000,000	1,610,000,000
EBITDA	$15.07B	$9.14B	$12.76B	$18.12B	$17.92B	$11.36B	$12.98B	$6.38B	$9.59B	$9.38B	$7.54B	$3.41B

Balance Sheet 25

Annual Balance Sheet data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$5.23B	$5.52B	$12.81B	$9.20B	$9.75B	$8.45B	$39.92B	$7.29B	$9.30B	$5.10B	$8.40B	$8.35B
Short-term Investments	$28M	$31M	$2M	$28M	$84M	$30M	$0	$772M	$486M	$1.32B	$8M	$26M
Receivables	$12.59B	$10.92B	$11.15B	$11.25B	$9.98B	$8.82B	$5.43B	$5.38B	$5.09B	$4.76B	$4.73B	·
Inventory	$4.95B	$4.18B	$4.10B	$3.58B	$3.13B	$3.31B	$1.81B	$1.60B	$1.60B	$1.44B	$1.72B	$1.12B
Current Assets	$29.06B	$25.58B	$33.00B	$28.46B	$27.93B	$24.17B	$49.52B	$16.95B	$21.22B	$16.19B	$16.31B	$16.08B
PP&E (Net)	$5.63B	$5.13B	$4.99B	$4.93B	$5.11B	$5.25B	$2.96B	$2.88B	$2.80B	$2.60B	$2.56B	$2.48B
PP&E (Gross)	$13.53B	$12.27B	$11.63B	$10.99B	$10.73B	$10.86B	$8.19B	$8.40B	$8.07B	$7.53B	$7.33B	$7.11B
Accum. Depreciation	$7.90B	$7.13B	$6.65B	$6.05B	$5.62B	$5.61B	$5.23B	$5.51B	$5.27B	$4.92B	$4.77B	$4.62B
Goodwill	$35.64B	$34.96B	$32.29B	$32.16B	$32.38B	$33.12B	$15.60B	$15.66B	$15.79B	$15.42B	$13.17B	$5.86B
Intangibles	$52.64B	$60.07B	$55.61B	$67.44B	$75.95B	$82.88B	$18.65B	$21.23B	$27.56B	$28.90B	$19.71B	$1.51B
Other Non-current Assets	$10.72B	$9.14B	$8.51B	$5.57B	$4.88B	$4.85B	$2.29B	$1.21B	$1.33B	$1.21B	$1.15B	$1.48B
Total Assets	$133.96B	$135.16B	$134.71B	$138.81B	$146.53B	$150.56B	$89.11B	$59.35B	$70.79B	$66.10B	$53.05B	$27.51B
Accounts Payable	$34.73B	$2.94B	$3.69B	$2.93B	$2.88B	$2.28B	$1.45B	$1.55B	$1.47B	$1.41B	$1.60B	$1.40B
Short-term Debt	$2.50B	$0	$0	$1M	$14M	$34M	$0	$3.70B	$400M	$377M	$406M	$425M
Current Liabilities	$43.29B	$38.75B	$37.84B	$29.54B	$35.19B	$28.66B	$15.59B	$17.24B	$16.64B	$9.78B	$10.89B	$11.39B
Capital Leases	$689M	$697M	$735M	$754M	$713M	$832M	·	·	·	·	·	·
Deferred Tax	$2.39B	$2.58B	$1.95B	$2.19B	$3.01B	$3.65B	$1.13B	$1.07B	$2.49B	$6.89B	$5.28B	$159M
Other Non-current Liabilities	$32.57B	$30.13B	$32.33B	$30.66B	$28.70B	$27.61B	$17.60B	$1.31B	$1.24B	$1.16B	$844M	$990M
Long-term Debt	$64.50B	$66.84B	$59.24B	$63.13B	$75.96B	$84.95B	$67.23B	·	·	·	·	·
Total Debt	$2.50B	·	$0	$1M	$14M	$34M	$0	$3.70B	$400M	$377M	$406M	$425M
Retained Earnings	$-15.49B	$-7.90B	$-1.00B	$4.78B	$3.13B	$1.05B	$4.72B	$3.37B	$5.46B	$4.38B	$2.25B	$535M
Treasury Stock	$9.15B	$8.20B	$6.53B	$4.59B	$3.14B	$2.26B	$24.50B	$24.11B	$11.92B	$10.85B	$8.84B	$972M
AOCI	$-1.14B	$-1.93B	$-2.31B	$-2.20B	$-2.90B	$-3.12B	$-3.60B	$-2.48B	$-2.73B	$-2.59B	$-2.56B	$-2.03B
Stockholders' Equity	$-3.27B	$3.33B	$10.36B	$17.25B	$15.41B	$13.08B	$-8.17B	$-8.45B	$5.10B	$4.64B	$3.94B	$1.74B
Liabilities + Equity	$133.96B	$135.16B	$134.71B	$138.81B	$146.53B	$150.56B	$89.11B	$59.35B	$70.79B	$66.10B	$53.05B	$27.51B

Cash Flow 17

Annual Cash Flow data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Stock-based Comp	$955M	$911M	$747M	$671M	$692M	$753M	$430M	$421M	$365M	$353M	$282M	$241M
Deferred Tax	$-492M	$-1.45B	$-2.89B	$-1.93B	$-898M	$-2.33B	$122M	$-1.52B	$-4.16B	$-796M	$152M	$-380M
Amort. of Intangibles	$7.38B	$7.62B	$7.95B	$7.69B	$7.72B	$5.80B	$1.55B	$1.29B	$1.08B	$764M	$419M	$403M
Restructuring	·	·	·	·	·	·	$219M	$59M	$86M	$52M	$126M	$16M
Operating Cash Flow	$19.03B	$18.81B	$22.84B	$24.94B	$22.78B	$17.59B	$13.32B	$13.43B	$9.96B	$7.04B	$7.54B	$3.55B
CapEx	$1.21B	$974M	$777M	$695M	$787M	$798M	$552M	$638M	$529M	$479M	$532M	$612M
Investing Cash Flow	$-6.64B	$-20.82B	$-2.01B	$-623M	$-2.34B	$-37.56B	$596M	$-1.01B	$-274M	·	·	·
Debt Issued	$3.99B	$16.96B	·	$2.00B	$1.00B	$3.00B	$31.48B	$5.96B	$0	$11.63B	$20.66B	·
Net Debt Issued	$3.99B	$16.96B	·	$2.00B	$1.00B	$3.00B	$31.48B	$5.96B	$0	$11.63B	$20.66B	·
Stock Repurchased	$980M	$1.71B	$1.97B	$1.49B	$934M	$978M	$629M	$12.01B	$1.41B	$6.03B	$7.59B	$665M
Net Stock Activity	$-980M	$-1.71B	$-1.97B	$-1.49B	$-934M	$-978M	$-629M	$-12.01B	$-1.41B	$-6.03B	$-7.57B	$-652M
Dividends Paid	$11.66B	$11.03B	$10.54B	$10.04B	$9.26B	$7.72B	$6.37B	$5.58B	$4.11B	$3.72B	$3.29B	$2.66B
Financing Cash Flow	$-12.72B	$-5.21B	$-17.22B	$-24.80B	$-19.04B	$-11.50B	$18.71B	$-14.40B	$-5.51B	$-3.93B	·	·
Net Change in Cash	$-295M	$-7.29B	$3.61B	$-545M	$1.30B	$-31.48B	$32.63B	$-2.01B	$4.20B	$-3.30B	$51M	$-1.25B
Taxes Paid	$3.63B	$4.10B	$4.70B	·	·	·	·	·	·	·	·	·
Free Cash Flow	$17.82B	$17.83B	$22.06B	$24.25B	$21.99B	$16.79B	$12.77B	$12.79B	$9.43B	$6.56B	$7.00B	$2.94B
Levered FCF	$15.96B	$14.59B	$20.33B	$22.29B	$19.84B	$13.45B	$11.10B	$11.31B	$8.64B	$5.77B	$6.45B	$2.62B

Profitability 7

Annual Profitability data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Operating Margin	24.6%	16.2%	23.5%	31.2%	31.9%	24.8%	39.0%	19.5%	34.0%	36.6%	33.0%	17.1%
Net Margin	6.9%	7.6%	8.9%	20.4%	20.5%	10.1%	23.7%	17.4%	18.8%	23.2%	·	·
Pretax Margin	10.8%	6.6%	11.5%	23.2%	23.1%	7.4%	25.3%	15.9%	27.4%	30.8%	29.1%	11.9%
EBITDA Margin	24.6%	16.2%	23.5%	31.2%	31.9%	24.8%	39.0%	19.5%	34.0%	36.6%	33.0%	17.1%
ROA	3.1%	3.2%	3.6%	8.3%	7.8%	3.9%	10.6%	8.7%	7.8%	10.0%	·	·
ROE	15367.3%	62.5%	35.2%	72.5%	81.0%	188.2%	-94.2%	-100.1%	109.1%	138.8%	·	·
ROIC	-1254.6%	317.0%	96.0%	92.3%	103.3%	117.9%	-148.6%	-147.1%	119.9%	141.3%	134.1%	117.9%

Liquidity & Solvency 4

Annual Liquidity & Solvency data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	0.7	0.7	0.9	1.0	0.8	0.8	3.2	1.0	1.3	1.7	1.5	1.4
Quick Ratio	0.4	0.4	0.6	0.7	0.6	0.6	2.9	0.8	0.6	0.7	0.8	0.7
Debt / Equity	-0.8	·	0.0	0.0	0.0	0.0	0.0	-0.4	0.1	0.1	0.1	0.2
Interest Coverage	5.2	3.3	5.7	8.1	7.4	4.6	7.3	4.7	8.3	9.0	10.5	8.0

Efficiency 3

Annual Efficiency data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.6	0.7
Inventory Turnover	4.0	4.1	5.3	5.2	5.4	6.0	4.4	4.8	4.6	3.7	3.2	3.9
Receivables Turnover	5.2	5.1	4.8	5.5	6.0	6.4	6.2	6.3	·	·	·	·

Per Share 5

Annual Per Share data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue / Share	$34.50	$31.77	$30.64	$32.65	$31.62	$27.38	$22.42	$21.19	$17.60	$15.72	$13.96	$12.40
Cash Flow / Share	$10.73	$10.61	$12.88	$14.03	$12.82	$10.51	$8.98	$8.69	$6.21	$4.32	$4.60	$2.20
Dividend / Share	$7	$6	$6	$6	$5	$5	$4	$4	$3	$2	$2	$2
Dividend Paid / Share	·	·	·	·	·	·	·	$4	$3	$2	·	·
EPS (TTM)	$2.36	$2.39	$2.72	$6.63	$6.45	$2.72	$5.28	$3.66	$3.30	$3.63	$3.13	$1.10

Growth Rates 10

Annual Growth Rates data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	8.6%	3.7%	-6.4%	3.3%	22.7%	·	·	·	·	·	·	·
Revenue CAGR 3Y	1.8%	0.08%	5.9%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	5.9%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	-1.3%	-12.1%	-59.0%	2.8%	137.1%	·	·	·	·	·	·	·
EPS CAGR 3Y	-29.1%	-28.2%	0.00%	·	·	·	·	·	·	·	·	·
EPS CAGR 5Y	-2.8%	·	·	·	·	·	·	·	·	·	·	·
Net Income YoY	-1.2%	-12.0%	-58.9%	2.5%	150.0%	·	·	·	·	·	·	·
Net Income CAGR 3Y	-29.1%	-28.2%	1.8%	·	·	·	·	·	·	·	·	·
Net Income CAGR 5Y	-1.8%	·	·	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	8.6%	·	·	·	·	·	·	·	·	·	·	·

Valuation (TTM) 6

Annual Valuation (TTM) data for ABBV
Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$61.16B	$56.33B	$54.32B	$58.05B	$56.20B	$45.80B	$33.27B	$32.75B	$28.22B	$25.64B	$22.86B	$19.96B
Net Income TTM	$4.23B	$4.28B	$4.86B	$11.84B	$11.54B	$4.62B	$7.88B	$5.69B	$5.31B	$5.95B	$5.14B	$1.77B
P/E	96.8	74.4	57.0	24.4	21.0	39.4	16.8	25.2	29.3	17.3	18.9	59.5
Earnings Yield	1.0%	1.3%	1.8%	4.1%	4.8%	2.5%	6.0%	4.0%	3.4%	5.8%	5.3%	1.7%
Payout Ratio	275.8%	257.7%	216.7%	84.9%	80.2%	167.2%	80.8%	98.1%	77.4%	62.4%	·	·
Annual Payout	$11.66B	$11.03B	$10.54B	$10.04B	$9.26B	$7.72B	$6.37B	$5.58B	$4.11B	$3.72B	$3.29B	$2.66B

Income Statement 17

Quarterly Income Statement data for ABBV
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$15.00B	$16.62B	$15.78B	$15.42B	$13.34B	$15.10B	$14.46B	$14.46B	$12.31B	$14.30B	$13.93B	$13.87B	$12.22B	$15.12B	$14.81B	$14.58B
Cost of Revenue	$4.22B	$4.55B	$5.30B	$4.35B	$4.00B	$4.40B	$4.21B	$4.20B	$4.09B	$5.70B	$6.49B	$4.24B	$3.99B	$4.17B	$5.02B	$4.17B
Gross Profit	·	$12.07B	·	·	·	$10.71B	·	·	·	$8.60B	·	·	·	$10.95B	·	·
SG&A Expense	$3.58B	$3.90B	$3.57B	$3.25B	$3.29B	$3.85B	$4.21B	$3.38B	$3.31B	$3.19B	$3.37B	$3.27B	$3.04B	$3.42B	$3.30B	$5.41B
Operating Expenses	$11.01B	$12.07B	$13.87B	$10.53B	$9.61B	$16.59B	$10.63B	$10.46B	$9.51B	$11.11B	$11.65B	$9.35B	$9.46B	$9.62B	$10.21B	$11.29B
Operating Income	$3.99B	$4.54B	$1.90B	$4.89B	$3.73B	$-1.49B	$3.83B	$4.00B	$2.80B	$3.19B	$2.28B	$4.51B	$2.77B	$5.50B	$4.60B	$3.29B
Interest Expense	$717M	$714M	$739M	$740M	$700M	$702M	$720M	$726M	$660M	$564M	$555M	$552M	$553M	$566M	$560M	$556M
Interest Income	$72M	·	$72M	$62M	$73M	·	$129M	$220M	$207M	·	$157M	$98M	$99M	·	$63M	$24M
Other Non-op	$-2.31B	$-1.21B	$-503M	$-2.64B	$-1.45B	$-150M	$-1.16B	$-1.34B	$-586M	$-1.56B	$95M	$-1.41B	$-1.80B	$-2.02B	$330M	$-1.53B
Pretax Income	$1.04B	$2.67B	$714M	$1.55B	$1.66B	$-2.27B	$2.08B	$2.15B	$1.75B	$1.21B	$1.95B	$2.61B	$475M	$2.96B	$4.40B	$1.18B
Income Tax	$342M	$853M	$526M	$613M	$372M	$-2.25B	$520M	$773M	$383M	$388M	$172M	$583M	$234M	$493M	$448M	$255M
Net Income	$695M	$1.82B	$186M	$938M	$1.29B	$-22M	$1.56B	$1.37B	$1.37B	$822M	$1.78B	$2.02B	$239M	$2.47B	$3.95B	$924M
EPS (Basic)	$0.39	$1.02	$0.10	$0.52	$0.72	$-0.02	$0.88	$0.77	$0.77	$0.46	$1.00	$1.14	$0.13	$1.39	$2.22	$0.52
EPS (Diluted)	$0.39	$1.02	$0.10	$0.52	$0.72	$-0.03	$0.88	$0.77	$0.77	$0.45	$1.00	$1.14	$0.13	$1.40	$2.21	$0.51
Shares (Basic)	1,770,000,000	-3,536,000,000	1,769,000,000	1,768,000,000	1,768,000,000	-3,537,000,000	1,769,000,000	1,768,000,000	1,769,000,000	-3,536,000,000	1,767,000,000	1,767,000,000	1,770,000,000	-3,541,000,000	1,771,000,000	1,770,000,000
Shares (Diluted)	1,774,000,000	-3,542,000,000	1,772,000,000	1,771,000,000	1,772,000,000	-3,543,000,000	1,772,000,000	1,771,000,000	1,773,000,000	-3,545,000,000	1,771,000,000	1,771,000,000	1,776,000,000	-3,552,000,000	1,776,000,000	1,776,000,000
EBITDA	$3.99B	·	$1.90B	$4.89B	$3.73B	·	$3.83B	$4.00B	$2.80B	·	$2.28B	$4.51B	$2.77B	·	$4.60B	$3.29B

Balance Sheet 25

Quarterly Balance Sheet data for ABBV
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$9.39B	$5.23B	$5.63B	$6.47B	$5.17B	$5.52B	$7.26B	$13.13B	$18.07B	·	$13.29B	$8.76B	$6.71B	·	$11.83B	$8.52B
Short-term Investments	·	$28M	$42M	$0	$1M	$31M	$28M	$27M	$2M	·	$3M	$7M	$11M	·	$47M	$1.44B
Receivables	$12.48B	$12.59B	$12.77B	$12.64B	$12.48B	$10.92B	$11.47B	$11.72B	$11.95B	·	$11.41B	$11.49B	$11.47B	·	$10.74B	$11.24B
Inventory	$5.05B	$4.95B	$4.94B	$4.96B	$4.53B	$4.18B	$4.45B	$4.22B	$4.25B	·	$3.98B	$4.05B	$3.83B	·	$3.17B	$3.40B
Current Assets	$33.53B	$29.06B	$28.54B	$29.26B	$27.68B	$25.58B	$27.79B	$33.82B	$38.87B	·	$33.22B	$28.85B	$26.49B	·	$30.36B	$29.10B
PP&E (Net)	$5.69B	$5.63B	$5.48B	$5.28B	$5.24B	$5.13B	$5.14B	$5.02B	$4.98B	·	$4.93B	$4.94B	$4.93B	·	$4.89B	$4.96B
PP&E (Gross)	$13.73B	$13.53B	$13.23B	$12.93B	$12.57B	$12.27B	$12.28B	$11.90B	$11.72B	·	$11.37B	$11.32B	$11.14B	·	$10.68B	$10.83B
Accum. Depreciation	$8.04B	$7.90B	$7.75B	$7.65B	$7.33B	$7.13B	$7.14B	$6.88B	$6.75B	·	$6.44B	$6.38B	$6.21B	·	$5.79B	$5.87B
Goodwill	$35.57B	$35.64B	$35.63B	$35.64B	$35.28B	$34.96B	$35.30B	$33.39B	$33.43B	$32.29B	$32.09B	$32.22B	$32.22B	$32.16B	$31.73B	$32.03B
Intangibles	$50.87B	$52.64B	$54.31B	$57.03B	$58.49B	$60.07B	$66.65B	$60.24B	$62.23B	·	$58.60B	$62.86B	$64.85B	·	$68.72B	$71.82B
Other Non-current Assets	$10.54B	$10.72B	$9.64B	$9.66B	$9.19B	$9.14B	$8.29B	$9.20B	$9.07B	·	$7.09B	$6.20B	$5.80B	·	$5.38B	$5.03B
Total Assets	$136.46B	$133.96B	$133.90B	$137.18B	$136.16B	$135.16B	$143.42B	$141.94B	$148.87B	·	$136.22B	$135.37B	$134.54B	·	$141.32B	$143.19B
Accounts Payable	$33.77B	$3.59B	$33.62B	$32.24B	$31.04B	$2.94B	$30.49B	$29.33B	$31.33B	·	$29.66B	$27.04B	$24.79B	·	$23.50B	$22.54B
Short-term Debt	$0	$2.50B	$3.79B	$5.56B	$1.59B	$0	·	·	$3M	·	$2M	$0	$1M	·	$10M	$17M
Current Liabilities	$42.10B	$43.29B	$39.39B	$39.77B	$36.40B	$38.75B	$43.06B	$41.91B	$41.52B	·	$34.77B	$32.24B	$27.59B	·	$32.71B	$34.47B
Capital Leases	·	$689M	·	·	·	$697M	·	·	·	·	·	·	·	·	·	·
Deferred Tax	$2.33B	$2.39B	$2.48B	$2.55B	$2.58B	$2.58B	$2.75B	$2.73B	$2.72B	·	$2.04B	$2.12B	$2.11B	·	$1.97B	$2.25B
Other Non-current Liabilities	$34.11B	$32.57B	$31.66B	$32.04B	$31.19B	$30.13B	$33.03B	$32.43B	$32.78B	·	$31.64B	$32.29B	$32.25B	·	$30.21B	$30.77B
Long-term Debt	·	$64.50B	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Total Debt	$0	·	$3.79B	$5.56B	$1.59B	·	·	·	$3M	·	$2M	$0	$1M	·	$10M	$17M
Retained Earnings	$-17.87B	$-15.49B	$-14.23B	$-11.50B	$-9.53B	$-7.90B	$-4.96B	$-3.77B	$-2.38B	·	$933M	$1.79B	$2.39B	·	$4.95B	$3.52B
Treasury Stock	$10.61B	$9.15B	$9.14B	$9.15B	$9.14B	$8.20B	$7.85B	$7.84B	$7.83B	·	$6.53B	$6.53B	$6.52B	·	$4.59B	$4.59B
AOCI	$-1.15B	$-1.14B	$-1.57B	$-1.54B	$-1.74B	$-1.93B	$-2.33B	$-2.51B	$-2.45B	·	$-2.35B	$-2.25B	$-2.23B	·	$-3.44B	$-3.20B
Stockholders' Equity	$-6.66B	$-3.27B	$-2.64B	$-183M	$1.42B	$3.33B	$6.03B	$6.78B	$8.01B	·	$12.09B	$12.87B	$13.27B	·	$15.99B	$14.65B
Liabilities + Equity	$136.46B	$133.96B	$133.90B	$137.18B	$136.16B	$135.16B	$143.42B	$141.94B	$148.87B	·	$136.22B	$135.37B	$134.54B	·	$141.32B	$143.19B

Cash Flow 15

Quarterly Cash Flow data for ABBV
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Stock-based Comp	$444M	$157M	$209M	$179M	$410M	$164M	$181M	$218M	$348M	$125M	$130M	$179M	$313M	$132M	$126M	$107M
Deferred Tax	$137M	$-385M	$193M	$-272M	$-28M	$-767M	$-277M	$-16M	$-389M	$-1.39B	$-863M	$-368M	$-267M	$-516M	$-621M	$-600M
Amort. of Intangibles	$1.75B	$1.72B	$1.90B	$1.90B	$1.86B	$1.93B	$1.90B	$1.90B	$1.89B	$1.90B	$2.00B	$2.10B	$1.95B	$2.03B	$2.00B	$1.80B
Operating Cash Flow	$3.83B	$5.22B	$7.02B	$5.15B	$1.64B	$7.05B	$5.45B	$2.27B	$4.04B	$4.75B	$7.57B	$6.32B	$4.19B	$7.43B	$7.60B	$5.00B
CapEx	$265M	$329M	$381M	$269M	$235M	$291M	$249M	$241M	$193M	$205M	$219M	$178M	$175M	$213M	$177M	$143M
Investing Cash Flow	$-574M	$-1.46B	$-3.26B	$-1.18B	$-735M	$-1.87B	$-8.26B	$-1.10B	$-9.59B	$-800M	$-369M	$-341M	$-499M	$-448M	$1.29B	$130M
Debt Issued	$7.99B	$0	$0	$0	$3.99B	$2.00B	$0	$0	$14.96B	·	$0	$0	$0	$0	$0	$0
Net Debt Issued	$7.99B	·	·	·	$3.99B	·	·	·	$14.96B	·	·	·	$0	·	·	·
Stock Repurchased	$1.49B	$3M	$4M	$12M	$961M	$358M	$17M	$9M	$1.32B	$3M	$4M	$10M	$1.96B	$4M	$4M	$9M
Net Stock Activity	$-1.49B	·	·	·	$-961M	·	·	·	$-1.32B	·	·	·	$-1.96B	·	·	·
Dividends Paid	$3.09B	$2.91B	$2.91B	$2.91B	$2.92B	$2.75B	$2.75B	$2.75B	$2.77B	$2.63B	$2.63B	$2.62B	$2.66B	$2.51B	$2.50B	$2.51B
Financing Cash Flow	$919M	$-4.17B	$-4.59B	$-2.71B	$-1.26B	$-6.86B	$-3.07B	$-6.10B	$10.82B	$-4.45B	$-2.66B	$-3.92B	$-6.19B	$-9.63B	$-5.52B	$-2.68B
Net Change in Cash	$4.16B	$-400M	$-838M	$1.29B	$-349M	$-1.73B	$-5.87B	$-4.94B	$5.25B	$-473M	$4.53B	$2.05B	$-2.49B	$-2.63B	$3.31B	$2.42B
Free Cash Flow	$3.56B	·	·	·	$1.40B	·	·	·	$3.85B	·	·	·	$4.02B	·	·	·
Levered FCF	$3.08B	·	·	·	$857M	·	·	·	$3.33B	·	·	·	$3.74B	·	·	·

Profitability 7

Quarterly Profitability data for ABBV
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	26.6%	·	12.1%	31.7%	28.0%	·	26.5%	27.6%	22.7%	·	16.4%	32.6%	22.6%	·	31.1%	22.6%
Net Margin	4.6%	·	1.2%	6.1%	9.6%	·	10.8%	9.5%	11.1%	·	12.8%	14.6%	2.0%	·	26.7%	6.3%
Pretax Margin	6.9%	·	4.5%	10.1%	12.4%	·	14.4%	14.8%	14.3%	·	14.0%	18.8%	3.9%	·	29.7%	8.1%
EBITDA Margin	26.6%	·	12.1%	31.7%	28.0%	·	26.5%	27.6%	22.7%	·	16.4%	32.6%	22.6%	·	31.1%	22.6%
ROA	0.51%	·	0.13%	0.67%	0.90%	·	1.1%	0.99%	0.97%	·	1.3%	1.5%	0.17%	·	2.7%	0.63%
ROE	-26.6%	·	11.0%	28.4%	27.3%	·	17.2%	14.0%	12.9%	·	12.7%	14.7%	1.6%	·	26.7%	6.8%
ROIC	-40.2%	·	43.7%	55.2%	96.2%	·	47.7%	37.7%	27.3%	·	17.2%	27.2%	10.6%	·	25.8%	17.6%

Liquidity & Solvency 4

Quarterly Liquidity & Solvency data for ABBV
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio	0.8	·	0.7	0.7	0.8	·	0.6	0.8	0.9	·	1.0	0.9	1.0	·	0.9	0.8
Quick Ratio	0.5	·	0.5	0.5	0.5	·	0.4	0.6	0.7	·	0.7	0.6	0.7	·	0.7	0.6
Debt / Equity	0.0	·	-1.4	-30.4	1.1	·	·	·	0.0	·	0.0	0.0	0.0	·	0.0	0.0
Interest Coverage	5.6	·	2.6	6.6	5.3	·	5.3	5.5	4.2	·	4.1	8.2	5.0	·	8.2	5.9

Efficiency 3

Quarterly Efficiency data for ABBV
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1
Inventory Turnover	0.9	·	1.1	0.9	0.9	·	1.0	1.0	1.0	·	1.8	1.1	1.1	·	1.6	1.2
Receivables Turnover	1.2	·	1.3	1.3	1.1	·	1.3	1.2	1.1	·	1.3	1.2	1.1	·	1.5	1.4

Per Share 4

Quarterly Per Share data for ABBV
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue / Share	$8.46	·	$8.90	$8.71	$7.53	·	$8.16	$8.17	$6.94	·	$7.86	$7.83	$6.88	·	$8.34	$8.21
Cash Flow / Share	$2.16	·	·	·	$0.92	·	·	·	$2.28	·	·	·	$2.36	·	·	·
Dividend / Share	$2	$2	$2	$2	$2	$2	$2	$2	$2	$2	$1	$1	$1	$1	$1	$1
EPS (TTM)	$2.03	·	$1.32	$2.10	$2.35	·	$2.88	$3.00	$3.37	·	$3.65	$4.86	$4.23	·	$7.49	$7.06

Valuation (TTM) 5

Quarterly Valuation (TTM) data for ABBV
Metric	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$62.82B	·	$59.64B	$58.33B	$57.37B	·	$55.53B	$55.00B	$54.40B	·	$55.14B	$56.02B	$56.74B	·	$57.82B	$57.35B
Net Income TTM	$3.63B	·	$2.39B	$3.76B	$4.20B	·	$5.12B	$5.34B	$5.99B	·	$6.51B	$8.69B	$7.58B	·	$13.41B	$12.64B
P/E	107.1	·	175.4	88.4	89.2	·	68.6	57.2	54.0	·	40.8	27.7	37.7	·	17.9	21.7
Earnings Yield	0.93%	·	0.57%	1.1%	1.1%	·	1.5%	1.8%	1.8%	·	2.5%	3.6%	2.6%	·	5.6%	4.6%
Payout Ratio	444.0%	·	·	·	227.5%	·	·	·	202.5%	·	·	·	1113.4%	·	·	·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$61.16B	$56.33B	$54.32B	$58.05B	$56.20B
Operating Margin %	24.6%	16.2%	23.5%	31.2%	31.9%
Net Income	$4.23B	$4.28B	$4.86B	$11.84B	$11.54B
Diluted EPS	$2.36	$2.39	$2.72	$6.63	$6.45

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	-0.8	—	0.0	0.0	0.0
Current Ratio	0.7	0.7	0.9	1.0	0.8
Quick Ratio	0.4	0.4	0.6	0.7	0.6

Cash Flow

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$17.82B	$17.83B	$22.06B	$24.25B	$21.99B

Latest News Recent headlines mentioning this company

Long-Term Optimism Yahoo Finance · 5 days, 22 hours ago
Analyst Report: AbbVie Inc Yahoo Finance · 6 days, 11 hours ago
AbbVie Stock: Is Wall Street Bullish or Bearish? Yahoo Finance · 1 week, 1 day ago
AbbVie (ABBV), adMare BioInnovations Name RIME Therapeutics as Biotech Innovators Award Winner Yahoo Finance · 1 week, 4 days ago
AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting Yahoo Finance · 1 week, 4 days ago
AbbVie tops quarterly expectations as newer immunology drugs offset Humira decline Yahoo Finance · 3 weeks ago
See Which Recent 13F Filers Hold ABBV But Capital Advisory Group Advisory Services, and Bright Futures Wealth Management Exited Nasdaq · 1 month ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

ABBV Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

ABBV Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

Moving averages & overlays

Volume

Oscillators

Momentum & trend

10-Year Performance Revenue, net income, margins and EPS trends

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Financial Health Debt, liquidity, solvency — balance sheet strength

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Dividends Yield, payout ratio, dividend history, 5Y CAGR

ABBV Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

12-Month Price Target

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Peer Comparison Key metrics vs sector peers

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Latest News Recent headlines mentioning this company

My Metrics Your personal watchlist — selected rows from Full Fundamentals